Table 1

Descriptive data of study variables (n=151)

VariablesMeanSDRange
Age72.08.655–93
Disease duration (month)74.061.12–389
Symptom severity6.85.40–22
Anticoagulation treatment knowledge35.919.30–92
 Warfarin (n=53)33.520.60–90.9
 NOACs (n=98)38.419.10–91.7
Satisfaction with services and anticoagulation treatment19.13.27–24
Perceived benefits of anticoagulation treatment20.12.513–25
Perceived barriers to anticoagulation treatment1.11.30–6
Self-efficacy for anticoagulant use32.96.118–39
Anticoagulation adherence8.81.97–15
  • NOACs, novel oral anticoagulants.